MedTrace Logo

Zenith TX2® Post-market Approval Study

NCT00813358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2021-06-04

Study results available
· View outcomes & findings →

Summary

The Zenith TX2® Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2® TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.

Conditions

  • Descending Thoracic Aortic Aneurysm

Interventions

DEVICE

Zenith TX2® TAA Endovascular Graft

Endovascular treatment with the study device

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-10
Primary Completion
2020-02-14
Completion
2020-03-23

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00813358 on ClinicalTrials.gov